Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Pembedahan dikatakan sebagai penyebab 40% kasus AKI di rumah sakit. Penelitian difokuskan pada pengaruh ekstravasasi cairan ke interstitial yang disebabkan karena kebocoran kapiler. Kebocoran kapiler juga mengakibatkan terjadinya mikroalbuminuria. Peningkatan CVP atau tekanan intraabdominal (IAP) akan menghasilkan penurunan filtrasi ginjal sesuai dengan derajat transmisi tekanan ke glomeruli. Penelitian ini dimaksudkan untuk melihat hubungan antara indeks kebocoran kapiler (CLI), mikroalbuminuria (ACR) dan efektif renal perfusion pressure (eRPP) sebagai prediktor AKI pada pasien pasca bedah abdomen mayor.Pasien dan metode: Penelitian merupakan studi kohort prospektif observasional pasien usia 18-65 tahun yang menjalani operasi bedah abdomen mayor sejak tanggal 29 Agustus sampai 21 Desember 2021 di RSUD Provinsi NTB dan mendapatkan total 76 subjek penelitian, dengan 2 pasien drop out. CLI, ACR, dan eRPP diukur pra-operasi, 12 jam dan 36 jam pasca bedah dengan kejadian AKI diamati hingga hari keempat pasca bedah. Uji statistik menggunakan uji chi square dilanjutkan cox- regresi.Hasil: Data observasi CLI pada jam ke-0 diperoleh RR 1,29 pada titik potong ROC CLI >50. Data observasi ACR pada jam ke-0 dan jam ke-12 masing-masing memperoleh RR 1,261 (p=0,104; 95% CI 1,003-1,586) dan RR 1,211 (p=0,10; 95% CI 1,017-1,444). Data eRPP pada setiap jam pengukuran pada analisis bivariate tidak bermakna secara statistik namun pada analisis multivariate menggunakan cox regresi untuk mengetahui hubungan CLI, ACR, dan eRPP terhadap kejadian AKI setelah di-adjusted variabel perancu pada jam ke-0 diperoleh nilai RR dari variabel eRPP sebesar 9,125 dengan p= 0,037; CI 95% = 1,141293 - 72,95725. Subyek dengan AKI mengalami mortalitas sebesar 31,58% dan berisiko 2,384 kali untuk mengalami kematian (p = 0,0351, CI 95% = 1,133-5,018).Kesimpulan: Subjek dengan nilai eRPP <40 berisiko 9,125 kali untuk mengalami AKI. Subyek yang mengalami AKI berisiko 2,384 kali untuk mengalami kematian.

---

Background: Surgery caused of 40% of AKI cases in hospital which often occurs in the early days up to 4 days after surgery. The pathophysiology of postoperative AKI is multifactorial, the study focused on the effect of extravasation of fluid into the interstitium caused by capillary leakage. Capillary leakage also results in microalbuminuria. An increase in CVP or intra-abdominal pressure (IAP) will result decrease in renal filtration according to the degree of pressure transmission to the glomeruli. This study was intended to examine the relationship between capillary leakage index (CLI), microalbuminuria (ACR) and effective renal perfusion pressure (eRPP) as predictors of AKI in patients after major abdominal surgery.

Patients and method: This is an observational analytic study with a prospective longitudinal cohort design with consecutive sampling of patients aged 18-65 years who underwent major abdominal surgery from August 29, 2021 to December 21, 2021. The study included a total of 76 subjects, with 2 patients dropped out. The variables were CLI, ACR, and eRPP were measured preoperatively, 12 hours postoperatively, and 36 hours postoperatively and the incidence of AKI was observed until the fourth postoperative day. Statistical test using chi square test then followed by logistic regression to assess multivariately if it meets the requirements.

Results: CLI observation data at hour 0 obtained RR 1.29 at the point of intersection ROC CLI >50. ACR observation data at hour 0 and hour 12 each obtained RR 1.261 (p=0.104; 95% CI 1.003-1.586) and RR 1.211 (p=0.10; 95% CI 1.017-1.444). The eRPP data at each hour of measurement in bivariate analysis was not statistically significant, but in multivariate analysis using cox regression to determined relationship between CLI, ACR, and eRPP on the incidence of AKI after adjusting confounding variables at 0th hour the RR value of the eRPP was 9.125 with p = 0.037; 95% CI = 1,141293 - 72,95725. Subject with AKI experience a mortality of 31,58% and 2.384 times risk of mortality (p = 0,0351, CI 95% = 1,133-5,018).

Conclusion: Subjects with eRPP value <40 have 9,125 times experiencing AKI. Subjects who experienced AKI had a 2,384 times risk of mortality."

"Latar Belakang: Coronavirus Disease 2019 (COVID-19) merupakan penyakit saluran pernafasan yang menjadi pandemi dasawarsa terakhir dan dapat menyebabkan disfungsi jantung. Galectin-3 diduga terkait dengan proses inflamasi yang berlanjut pada remodelling dan akhirnya fibrosis organ. Diharapkan penilaian terhadap Galectin-3 akan memperoleh gambaran perburukan jantung pasien COVID-19 sehingga diperoleh data faktor-faktor yang berpengaruh terhadap peningkatan Left Ventricular End Diastolic Volume (LVEDV) yang nantinya menjadi gagal jantung pada pasien COVID-19.Metode: Rancangan penelitian ini adalah observasional prospektif analitik di ICU COVID-19 RSUP Sanglah. Penelitian dilakukan sejak bulan Juni sampai Oktober 2021. Semua subjek penelitian diperiksa kadar Galectin-3 menggunakan pemeriksaan Enzyme-Linked Immunosorbent Assay (ELISA). Subjek juga dilakukan evaluasi Left Ventricular End Diastolic Volume (LVEDV) dengan ekokardiografi, diidentifikasi menggunakan skor SOFA saat di ICU COVID-19, serta pemeriksaan terhadap kadar Troponin I. Subjek penelitian tetap akan mendapat terapi COVID-19 sesuai dengan protokol standar Kementerian Kesehatan RI. Setelah 72 jam pasca admisi ICU COVID-19, subjek penelitian akan dilakukan pemeriksaan ulangan terhadap kadar Galectin-3 dan LVEDV. Data yang didapatkan dianalisis dengan uji statistik menggunakanSTATATM.Hasil: Didapatkan total 45 subjek penelitian. Dari hasil analisis bivariat terhadap selisih Galectin-3 dengan LVEDV didapatkan tidak signifikan (r=0,08), uji korelasi antara Galectin-3 dan LVEDV saat masuk ruang rawat ICU ternyata tidak signifikan (r=0,191), dan korelasi antara Galectin-3 dan LVEDV pasca rawat 72 jam juga tidak signifikan (r=0,197). Dari hasil multivariat variabel bebas yakni selisih Galectin-3, usia, jenis kelamin, troponin I, skor SOFA dan CHARLSON terhadap variabel LVEDV ternyata tidak ada satu pun variabel yang memiliki hasil yang bermakna secara statistik (p<0,05) terhadap LVEDV.Simpulan: Tidak ada korelasi antara Galectin-3 dengan peningkatan LVEDV dalam penelitian ini

---

.

Background: Coronavirus Disease 2019 (COVID-19) is a respiratory disease that has become the largest pandemic and also could put heart at risk of dysfunction. Galectin-3 is thought to be related to the inflammatory process that continues with remodeling and eventually fibrosis. By using Galectin-3 assesment, we could overview the possible worsening of the heart and evaluate data on influencing factors in increased Left Ventricular End Diastolic Volume (LVEDV) which could later become heart failure.

Methods: This is an observational prospective analytic study in the COVID-19 ICU of Sanglah Hospital. The study was started from June to October 2021. All research subjects will have their blood samples taken for Galectin-3 levels using Enzyme-Linked Immunosorbent Assay (ELISA). Subjects were also evaluated for Left Ventricular End Diastolic Volume (LVEDV) with echocardiography, identified using SOFA scores, and also examined their Troponin I levels. Subjects were treated with COVID-19 standard protocol from the Health Ministry. After 72 hours post-admission, subjects were re-examined for Galectin-3 levels and LVEDV. The data were analyzed by statistical tests using STATATM.

Results: A total of 45 research subjects were analysed. Bivariate analysis of the difference of Galectin-3 and LVEDV shown to be insignificant (r=0.08), no correlation was found between Galectin-3 level and LVEDV while admitted to the ICU (r=0.191), and no correlation found between Galectin-3 level and LVEDV after 72 hours of hospitalization (r=0.197). Multivariate analysis also showed that none of variables namely difference of Galectin-3 level, age, gender, troponin I, SOFA and CHARLSON had statistically significant results (p<0.05) on LVEDV.

Conclusions: No correlation was found between Galectin-3 level and an increase in LVEDV."

"Latar Belakang: Janus Kinase (JAK)-inhibitors telah digunakan untuk terapi beberapa penyakit inflamasi dan autoimun karena kemampuannya untuk mengendalikan respon imun dan cytokine release syndrome. Saat ini penggunaan baru dari Janus Kinase (JAK)-inhibitors diperuntukan untuk terapi coronavirus disease 2019 (Covid-19), namun bukti mengenai kegunaannya masih belum jelas. Penelitian ini dilakukan untuk menganalisa efikasi dari Janus Kinase (JAK)-inhibitors untuk mengurangi mortalitas pasien Covid-19.Tujuan: Mengetahui efek pemberian terapi Janus Kinase (JAK)-inhibitors terhadap mortalitas pasien Covid-19.Metode: Dengan menggunakan kata kunci spesifik, dilakukan pencarian artikel potensial secara komprehensif pada PubMed, Europe PMC, and ClinicalTrials.gov database dengan pembatasan waktu sampai 2 Juni 2021. Semua penelitian tentang Covid-19 dan JAK-inhibitors dimasukan. Analisa statistik dilakukan denganReview Manager 5.4 software.Hasil: 13 penelitian dengan 4339 pasien Covid-19 dimasukan dalam meta-analisis. Data kami menyimpulkan bahwa terapi JAK-inhibitors berhubungan dengan menurunnya mortalitas pasien Covid-19 (RR 0.52; 95%CI: 0.36-0.76, p=0.0006, I2 = 33%, random-effect modelling).Kesimpulan: Penelitian ini menyimpulkan terapi JAK-inhibitors berhubungan dengan menurunnya mortalitas pasien Covid-19. Namun dibutuhkan randomized clinical trials yang lebih banyak untuk mengkonfirmasi hasil penelitian ini.

---

Background: : Janus Kinase (JAK)-inhibitors have been used for treating several inflammatory and autoimmune disease because of its ability to restrains immune systems and cytokine release syndrome. Currently, JAK-inhibitors are repurposed for the treatment of coronavirus disease 2019 (Covid-19), however the evidence regarding their benefit are still unclear. This study sought to analyze the efficacy of JAK-inhibitors in improving the mortality outcomes of Covid-19 patients.

Objective: To determine the effect of JAK-inhibitors as therapy in Covid-19 patients related to mortality.

Methods: Using specific keywords, we comprehensively searched the potential articles on PubMed, Europe PMC, and ClinicalTrials.gov database until June 2nd, 2021. All published studies on Covid-19 and JAK-inhibitors were retrieved. Statistical analysis was conducted using Review Manager 5.4 software.

Results: A total of 13 studies with 4,339 Covid-19 patients were included in the meta-analysis. Our data suggested that JAK-inhibitors was associated with reduction of mortality from Covid-19 (RR 0.52; 95%CI: 0.36 – 0.76, p=0.0006, I2 = 33%, random-effect modelling).

Conclusion: Our study suggests that JAK-inhibitors may offer beneficial effects on Covid-19 mortality. However, more randomized clinical trials warrant to confirm the findings of our study."

"Latar Belakang: Intensive care unit-acquired weakness (ICU-AW) adalah salah satu masalah yang dihadapi dalam manajemen pasien kritis karena dihubungkan dengan ventilasi mekanik berkepanjangan sehingga meningkatkan risiko komplikasi dan mortalitas selama di ICU. Mobilisasi dini seperti neuromuscular electrical stimulation (NMES) dilaporkan bermanfaat mengurangi durasi penggunaan ventilator di ICU. Telaah sistematik dan meta-analisis ini dibuat untuk menyimpulkan dampak dari NMES terhadap durasi penggunaan ventilator di ICU. Tujuan: Mengetahui dampak spesifik penggunaan NMES terhadap durasi penggunaan ventilator pada pasien ICU. Metode: Studi eligibel hingga Januari 2022 terinklusi dalam studi. Pencarian literatur dilakukan melalui database jurnal berbasis elektronik yaitu Cochrane, EBSCOHost, Scopus, dan Pubmed dengan kata kunci spesifik dan operator boolean. Studi terinklusi dievaluasi untuk risiko bias dengan Cochrane RoB 2 dan estimasi besar efek dilakukan dengan fixed effect model menggunakan perangkat lunak Review Manager 5.4. Hasil: Pencarian literatur menghasilkan 9 studi yang terinklusi dalam meta-analisis. Dari penggabungan data, disimpulkan bahwa penggunaan NMES berhubungan dengan penurunan durasi penggunaan ventilator (MD -1.48; 95% CI: -2,54 – -0,41, p = 0,007, I 2 =30%, fixed-effect modelling). Kesimpulan: Penelitian ini menyimpulkan bahwa pemberian NMES dapat menurunkan durasi penggunaan ventilator di ICU.

---

Background: Intensive Care Unit-Acquired Weakness (ICU-AW) is one of the problems faced in critical medicine management, associated with prolonged mechanical ventilation (PMV) thereby increasing risk and mortality while in the ICU. Early mobilization such as neuromuscular electrical stimulation (NMES) has been reported to be beneficial in reducing the duration of mechanical ventilation in the ICU. This systematic review and meta-analysis was conducted to conclude the impact of NMES on the duration of mechanical ventilation in the ICU. Objective: To determine the impact of the use of NMES on duration of mechanical ventilation in ICU patients. Methods: Eligible studies up to January 2022 were included in the study. The literature search was carried out through electronic-based journal databases, namely Cochrane, EBSCOHost, Scopus, and Pubmed with specific keywords and boolean operators. The included studies were evaluated for risk of bias with Cochrane RoB 2 and estimation of effect size was performed using a fixed effect modelling using Review Manager 5.4 software. Results: The literature search yielded 9 studies that were included in the meta- analysis. From the pooled data, it was concluded that NMES administration was associated with a decrease in the duration of mechanical ventilation (MD -1.48; 95% CI: -2.54 – -0.41, p = 0.007, I2 = 30%, fixed-effect modeling). Conclusion: This study concluded that the administration of NMES reduces the duration of ventilator use in the ICU."

"Penggunaan ventilasi mekanis pada pasien kritis tidak dapat dihindarkan namun dapat menyebabkan ventilator-induced lung injury (VILI) dan ventilator-induced diaphragm dysfunction (VIDD). Penelitian ini bertujuan untuk menilai hubungan antara volume tidal rendah (6 ml/kgBB) dan tinggi (10 ml/kgBB) terhadap disfungsi diafragma. Penelitian ini merupakan sebuah randomized controlled trial yang dilakukan di ruang perawatan intensif, RS Cipto Mangunkusumo. Pasien secara random masuk ke kelompok volume tidal 6 ml/kgBB dan 10 ml/kgBB, dan diikuti selama 72 jam (3 hari) untuk dinilai adanya disfungsi diafragma. Disfungsi diafragma dinilai menggunakan alat ultrasonografi, menggunakan kriteria ekskursi dan fraksi ketebalan diafragma. Variabel lain yang dinilai dalam penelitian ini ialah kadar interleukin-6.Sebanyak 52 pasien dilakukan randomisasi. Sebanyak total 45 pasien menyelesaikan studi. Tidak terdapat perbedaan karakteristik dasar sampel pasien pada kedua kelompok volume tidal. Sebanyak 37.8% pasien mengalami disfungsi diafragma pada hari ketiga. Tidak terdapat perbedaan proporsi disfungsi diafragma pada kedua kelompok volume tidal baik menggunakan kriteria ekskursi, fraksi ketebalan, maupun salah satunya. Terdapat perbedaan rerata interleukin-6 hari nol antara kelompok dengan dan tanpa disfungsi diafragma hari ketiga sebesar 332.29 pg/mL (p=0.024). Sebagai kesimpulan, volume tidal 6 ml/kgbb dan 10 ml/kgbb tidak berbeda dalam mencegah disfungsi diafragma pada pasien kritis. Interleukin-6 memiliki pengaruh terhadap disfungsi diafragma.

---

The use of mechanical ventilation is inevitable for critically ill patients yet it causes tremendous side effect of ventilator-induced lung injury (VILI) and ventilator-induced diaphragm dysfunction (VIDD). This study is aimed to examine the effect of low tidal volume (6 ml/kgBW) and high tidal volume (10 ml/kgBW) to diaphragm dysfunction. This is a randomized controlled trial conducted at intensive care unit (ICU) of Cipto Mangunkusumo Hospital. Patients were randomly allocated to tidal volume of 6 ml/kgBW or 10 ml/kgBW and were followed for 72 hours (3 days). At the end of the 72 hours, patients were assessed for diaphragm dysfunction. Diaphragm dysfunction is assessed by ultrasonography with excursion and thickness fraction criteria. Interleukin-6 was also examined. Of 52 patients who were randomized, 25 were on 6 ml/kgBW group and 27 were on the other. There were 45 patients finishing the study. The baseline characteristics of the sample was not different among the two groups. We found 37.8% patients with diaphragm dysfunction on day-3 but no significant proportion difference among the two groups. Diaphragm dysfunction was assessed with excursion, fraction of thickness criteria. We found 332.29 pg/mL mean difference between interleukin-6 on patients with and without diaphragm dysfunction on day-3 (p=0.024). In conclusion, tidal volume of 6 ml/kgBW and 10 ml/kgBW is not different in preventing diaphragm dysfunction on critically ill."